Alatovic, Jasmina (BioNTech 202005 Senior Manager Global External Communications) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Mainz |
Ali, Mohammed (Boehringer 202002 Global Head of Digital Development Global Clinical Operations) |
n. a. |
Boehringer Ingelheim (Group) |
Ingelheim |
Antipov, Alexei |
n. a. |
PlasmaChem GmbH |
Mainz |
Baechler, Guido (Mainz Biomed 202111 CEO before Singulex 201305– CEO before SVP Operations before Roche Dx) |
Chief Executive Officer (CEO) |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Mainz |
Ballnat, Thomas (Instraction GmbH 201402 Managing Director before Consultant before Pall GmbH) |
Managing Director |
InstrAction GmbH |
Ludwigshafen |
Banchi, Alessandro (Boehringer 200804 Chairman of Board of Managing Directors) |
n. a. |
Boehringer Ingelheim (Group) |
Ingelheim |
Barner, Andreas (Boehringer) |
Board member |
Boehringer Ingelheim (Group) |
Ingelheim |
Barth, Jörg (Boehringer Ingelheim 201507 Corporate SVP Therapy Area Head Oncology) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Berg, Wigbert (Orgentec 200905 Managing Director) |
Managing Director |
Orgentec (Group) |
Mainz |
Blair, Rainer M. (Danaher 2022 CEO before EVP Life Sciences + Head Life Sciences + AB Sciex + Videojet + MAPEI + BASF) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
Washington, D.C. |
Blanarik, Ivan (Boehringer 201707 SVP + Head Therapeutic Area Biosimilars) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Boehler, Michael (BioNTech 201905 Head of Global External Communications) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Mainz |
Boehringer, Christian (Boehringer 201207 Chairman of Shareholders’ Committee) |
Board member, non-executive |
Boehringer Ingelheim (Group) |
Ingelheim |
Boehringer, Christoph (Mediatum 2001– Managing Director + CD-Venture 2003– Managing Director + co-owner Boehringer) |
Managing Director |
Mediatum (Group) |
Heidelberg |
Boehringer, Mathias Albert (Boehringer 200809 Gesellschafterausschuss) |
n. a. |
Boehringer Ingelheim (Group) |
Ingelheim |
Bonert, Christian (ipOcean Global GmbH 202004 Managing Director) |
Managing Director |
ipOcean Global GmbH |
Mainz |
Brand, Alexandra (BASF 201305 SVP Animal Nutrition Business) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Ludwigshafen |
Brouillon, Carinne (Boehringer Ingelheim 201911 Head of Global Therapeutic Areas) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Buecheler, Uwe (Boehringer 201901 Head of Biopharmaceutical Business Unit) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Burger, Joachim (Univ Mainz 201211 Professor) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Mainz |
Carius, Wolfram (Bayer 202012 Head of Cell + Gene Therapy Unit before Boehringer) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Berlin |
Carter, Adrian (Boehringer Ingelheim 201207 Corporate VP Global Research Networking) |
Business Development Manager / Strategy Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Casarosa, Paola (Boehringer 202401– Managing Director Innovation Unit before Global Head Therapeutic Areas joined 2007) |
Business Development Manager / Strategy Manager |
Boehringer Ingelheim Innovation Unit |
Ingelheim |
Chatziathanasiou, Mathäos (MZ-Analysentechnik 201402 Managing Director) |
Managing Director |
MZ-Analysentechnik GmbH |
Mainz |
Conradt, Monika (Evotec 201606– Global Head Human Resources before Boehringer HR Manager Europe) |
Human Resources Manager |
Evotec (Group) |
Hamburg |
Corsico, Christopher (Boehringer 201708 CMO) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Ingelheim |
Czeloth, Niklas (Boehringer 202311 Executive Director + Investment Manager at BIVF) |
Investment Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Deshpande, Shashank (Boehringer 202401– Managing Director Animal Health Business Unit before Managing Director Japan) |
Managing Director |
Boehringer Ingelheim (Group) |
Ingelheim |
Dorner-Ciossek, Cornelia (Boehringer 202212 Digital Health Head) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Draheim, Henning (Boehringer Ingelheim 201111) |
Researcher (industry) |
Boehringer Ingelheim (Group) |
Ingelheim |
Drees, Ulrich (Boehringer Ingelheim 201301 Corporate SVP International Project Management) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Dreyer, Malu (Rheinland-Pfalz (govt) 202305 Ministerpräsidentin) |
Minister |
Rheinland-Pfalz (govt region) |
Mainz |
Dubourg, Saori (BASF 201909 Executive Board Director) |
Board member, executive |
BASF (Group) |
Ludwigshafen |
Dugi, Klaus (Vandria 2021– CEO before Boehringer + Ferring) |
Chief Executive Officer (CEO) |
Vandria S.A. |
Lausanne VD |
Ehlgen, Alexander (Boehringer 201910– Investment Manager Digital Health joined 201209 before BMS) |
Investment Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Eidens, Moritz (Mainz Biomed 202111 CSO before PharmGenomics GmbH 201601 Managing Director) |
Managing Director |
PharmGenomics GmbH |
Mainz |
Elbers, Knut (Boehringer Ingelheim 201204 Investment Manager + Director Boehringer Ingelheim Venture Fund) |
Investment Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Escher, Klaus |
n. a. |
BASF (Group) |
Ludwigshafen |
Fang, Peter (Boehringer 202002 SVP + Head of Therapeutic Area Inflammation) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Geissler, Holger (ipOcean Global GmbH 202004 Managing Director) |
Managing Director |
ipOcean Global GmbH |
Mainz |
Giese, Armin (Modag 201909 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Modag GmbH |
Wendelsheim |
Günster, Engelbert (Boehringer Ingelhead 201204–201402 Country Head Germany RETIRED 3/14) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Hackenberger, Alfred (BASF 1981–) |
n. a. |
BASF (Group) |
Ludwigshafen |
Haehl, Manfred (Boehringer 200905 Corrporate SVP Medicine) |
n. a. |
Boehringer Ingelheim (Group) |
Ingelheim |
Hambrecht, Jürgen (BASF AG 200501 CEO) |
Chief Executive Officer (CEO) |
BASF (Group) |
Ludwigshafen |
Hanekamp, Annemarie (BioNTech 202407– CCO before Novartis + BMS) |
Chief Commercial Officer (CCO) |
BioNTech (Group) |
Mainz |
Hasenmaier, Joachim (Boehringer 201210– Managing Director responsible for Consumer Healthcare + Animal Health) |
Managing Director |
Boehringer Ingelheim (Group) |
Ingelheim |
Hasskarl, Horst |
n. a. |
AbbVie (Group) |
Ludwigshafen |
Heidecker, Martin (AMR Action Fund 202301 Chief Investment Officer before Boehringer Ingelheim Venture Fund) |
Investment Manager |
AMR Action Fund |
ALL |
Heinricht, Frank (Schott 202108 CEO) |
Chief Executive Officer (CEO) |
Schott (Group) |
Mainz |
Heldt, Markus (BASF 201310 President of Crop Protection division) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Ludwigshafen |
Herrmann, Brigitte (Rheinland-Pfalz (govt) 201601 Head of Venture Capital at ISB) |
Investment Manager |
Investitions- und Strukturbank Rheinland-Pfalz (ISB) |
Mainz |
Heumann, Klaus (Univ Mainz 200701 Professor for Inorganic and Analytical Chemistry) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Mainz |
Hillgrove, Allan (Boehringer 201301– promoted Managing Director Div Marketing + Sales Prescription Medicines) |
Managing Director |
Boehringer Ingelheim (Group) |
Ingelheim |
Hinzen, Dieter (BI 200409) |
n. a. |
Boehringer Ingelheim (Group) |
Ingelheim |
Hofacher, Werner (Orgentec 201506 CEO) |
Chief Executive Officer (CEO) |
Orgentec (Group) |
Mainz |
Hofe, Thorsten (Polymer Standards Service 202208 Managing Director) |
Managing Director |
Agilent (Group) |
Mainz |
Hoffmann, Thomas (Phenex 201106 CFO) |
Chief Financial Officer (CFO) |
Phenex Pharmaceuticals AG |
Heidelberg |
Holstein, Jens (BioNTech 202107– CFO before MorphoSys 201105–202012 CFO before Fresenius Kabi) |
Chief Financial Officer (CFO) |
BioNTech (Group) |
Mainz |
Horowicz, Michael (BioNTech 202304 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Mainz |
Huber, Christoph (CI3 Cluster 201307 Board Member of CI3 e.V.) |
n. a. |
Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.) |
Mainz |
Jager, Martin (BASF 201202 Global Head Animal Nutrition Business) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Ludwigshafen |
Jamal, Waheed (Boehringer Ingelheim 201912 Corp VP + Head of CardioMetabolic Medicine) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Jehle, Regina (Abivax 201912– Director of Communications before BioNTech 2014– 2019) |
Public Relations Manager / Investor Relations Manager |
Abivax (Group) |
Paris |
Jennewein, Amélie (Jennewein Biotechnologie GmbH Co-Founder) |
Company Founder |
Chr. Hansen (Group) |
Rheinland-Pfalz (town unspecified) |
Jennewein, Klaus (Jennewein Biotechnologie GmbH 201512 Managing Director + Co-Founder) |
Managing Director |
Chr. Hansen (Group) |
Rheinland-Pfalz (town unspecified) |
Jennewein, Stefan (Jennewein Biotechnologie GmbH Co-Founder) |
Company Founder |
Chr. Hansen (Group) |
Rheinland-Pfalz (town unspecified) |
Jensen, Jan Nygaard (Boehringer 202210 Global Head of Computational Biology + DIgital Sciences) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |
Kaiser, Heinz (Schott 201906 Board Member responsible for diagnostics business) |
Board member, executive |
Schott (Group) |
Mainz |
Kaletta, Titus (Numares 201607– Executive Board Member COO before Consulting + Galantos Pharma + Devgen) |
Chief Operating Officer (COO) |
Numares (Group) |
Regensburg |
Kalkbrenner, Frank (Boehringer 201308 CVP + Head of BIVF + CEO Acousia Therapeutics GmbH) |
Investment Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Kallien, Peter (b.value AG 201610 Managing Partner + Founder plus Instraction GmbH 201402 Managing Director) |
Managing Director |
b.value (Group) |
Düsseldorf |
Khairi-Taraki, Tarrin (Mainz Biomed 202310– VP of Commercial Operations EMEA) |
Sales Manager / Marketing Manager |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Mainz |
Kissel, Karsten (Boehringer 201711 Head Global Medical Affairs Biosimilars) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Ingelheim |
Kluge, Peter (Qiagen 201205 Senior Sales Manager DE + AT + CH + NL for Ipsogen) |
Sales Manager / Marketing Manager |
Qiagen (Group) |
Ingelheim |
Knoll, Wolfgang |
n. a. |
Max Planck Society for the Advancement of Science |
Mainz |
Konstantinides, Stavros (Univ Mainz 201406 Professor) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Mainz |
Kostka, Marcus (Abalos Therapeutics 201909– Managing Director (CEO) before Boehringer Ingelheim Venture Fund) |
Chief Executive Officer (CEO) |
Abalos Therapeutics GmbH |
Düsseldorf |
Kraut, Norbert (Boehringer Ingelheim 201909 Head of Global Cancer Research) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Krebs, Rolf (Boehringer + Epigenomics Board etc) |
n. a. |
Boehringer Ingelheim (Group) |
Ingelheim |
Kremoser, Claus (Phenex 201106 CEO) |
Chief Executive Officer (CEO) |
Phenex Pharmaceuticals AG |
Heidelberg |
Kreuz, Sebastian (Boehringer 20207 at Boehringer Ingelheim Venture Fund) |
Investment Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Kreuzer, Jörg (Boehringer Ingelheim 201604 VP Medicine, Therapeutic Area Cardiovascular) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Ingelheim |
Kriegsmann, Jörg (MVZ Trier + MPT Trier 201610 Professor + Founder + Owner) |
n. a. |
MVZ für Histologie, Zytologie und Molekulare Diagnostik Trier (Dr. Kriegsmann + Dr. Otto) |
Trier |
Kring, Michael Maximilian (High Tech Corporate Services GmbH 201402 Managing Director + interim CFO/CEO others) |
Managing Director |
High Tech Corporate Services GmbH |
München (Munich) |
Kühlcke, Klaus (BioNTech 201309 Managing Director of Eufets GmbH) |
Managing Director |
BioNTech (Group) |
Idar-Oberstein |
Köppen, Herbert (Boehringer Ingelheim Pharma GmbH 200302 Head Cheminformatics) |
n. a. |
Boehringer Ingelheim (Group) |
Ingelheim |
Lange, Stephan (Boehringer Ingelheim 201908 Head Animal Health for Greater China) |
Regional manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Lauterbach, Enise (Lemoa 202003– Managing Director + Founder) |
Managing Director |
Lemoa (Group) |
Trier |
Leigh, Darin (Mainz Biomed 202204– CCO before CDR Health + Metabolon + Asuragen + Luminex + Abbott) |
Chief Commercial Officer (CCO) |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Mainz |
Levin, Johannes (Modag 201909– CMO main orgs LMU + DZNE) |
Chief Medical Officer (CMO) |
Modag GmbH |
Wendelsheim |
Lohfink, Martin (up to data 201003 Managing Director) |
Managing Director |
up to data professional services GmbH |
Wörrstadt |
Maas, Sylke (BioNTech 202005 VP Investor Relations + Business Strategy) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Mainz |
Maelicke, Alfred (Galantos 201309 Managing Director + Founder of Galantos Pharma) |
Managing Director |
Galantos (Group) |
Mainz |
Malin, Reinhard (Boehringer Ingelheim 201505 Director Media + PR) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Marcinowski, Stefan (BASF 201002 + 2008– VP Max Planck Society + 201002– Member BioÖkonomieRat) |
n. a. |
BASF (Group) |
Ludwigshafen |
Marett, Sean (BioNTech 202012–202406 CBO + CCO 201506 COO before Evotec RETIRED 6/24 continuing as advisor) |
Chief Operating Officer (COO) |
BioNTech (Group) |
Mainz |
Marston, Hugh (Boehringer 202403 Global Head CNS Discovery Research) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Ingelheim |
Maskos, Michael (Institut für Mikrotechnik Mainz GmbH 201109– Managing Director) |
Managing Director |
Fraunhofer (Group) |
Mainz |
Mbow, Lamine (Boehringer 202301 Global Head of Cancer Immunology + Immuned Modulation) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Ingelheim |